scholarly journals The importance of hormesis to public health

2007 ◽  
Vol 12 (4) ◽  
pp. 955-963 ◽  
Author(s):  
Ralph Cook ◽  
Edward J. Calabrese

Hormesis is a specific type of nonmonotonic dose response whose occurrence has been documented across a broad range of biological models and diverse types of exposure. The effects that occur at various points along this curve can be interpreted as beneficial or detrimental, depending on the biological or ecologic context in which they occur. Because hormesis appears to be a relatively common phenomenon that has not yet been incorporated into regulatory practice, the objective of this commentary is to explore some of its more obvious public health and risk assessment implications, with particular reference to issues raised recently within this journal by other authors. Hormesis appears to be more common than doseresponse curves that are currently used in the risk assessment process. Although a number of mechanisms have been identified that explain many hormetic doseresponse relationships, better understanding of this phenomenon will likely lead to different strategies not only for the prevention and treatment of disease but also for the promotion of improved public health as it relates to both specific and more holistic health outcomes. We believe that ignoring hormesis is poor policy because it ignores knowledge that could be used to improve public health.

1993 ◽  
Vol 9 (4) ◽  
pp. 439-447 ◽  
Author(s):  
Francisco J. R. Paumgartten

Virtually all chemical substances may cause adverse health effects, depending on the dose and conditions under which individuals are exposed to them. Toxicology - the study of harmful effects of chemicals on living organisms - provides the scientific data base on which risk assessment of adverse health effects stands. Risk assessment (RA) is the process of estimating the probability that a chemical compound will produce adverse effects on a given population, under particular conditions of exposure. Risk assessment process consists of four stages: Hazard Identification (HI), Exposure Assessment (EA), Dose-Response Assessment (DRA), and Risk Characterization (RC). The risk assessment process as a whole makes it possible to carry out cost(risk)/benefit analysis, and thus risk management, on a rational basis. A capacity to undertake risk assessment is thus sine qua non for making decisions that are concerned with achieving a balance between economic development and adequate protection of public health and the environment.


Sign in / Sign up

Export Citation Format

Share Document